<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03230000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P68133</UniProt_ID>
  <Seq_Length>377</Seq_Length>
  <Molecule_Weight>42051</Molecule_Weight>
  <KEGG_ID>hsa:58</KEGG_ID>
  <Orthology_ID>K10354</Orthology_ID>
  <Function_Summary>Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.</Function_Summary>
  <Pfam_ID>PF00022:Actin</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>10</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Alpha-actin-1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any part of a myosin complex; myosins are any of a superfamily of molecular motor proteins that bind to actin and use the energy of ATP hydrolysis to generate force and movement along actin filaments.</Detail>
      <Keyword>Myosin binding</Keyword>
      <Ontology_ID>GO:0017022</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ADP, adenosine 5'-diphosphate.</Detail>
      <Keyword>ADP binding</Keyword>
      <Ontology_ID>GO:0043531</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>The action of a molecule that contributes to the structural integrity of a cytoskeletal structure.</Detail>
      <Keyword>Structural constituent of cytoskeleton</Keyword>
      <Ontology_ID>GO:0005200</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Characteristic protein of a muscle cell. The major ones are myosin and actin, which are responsible for the contraction and relaxation of muscles.</Detail>
      <Keyword>Muscle protein</Keyword>
      <Ontology_ID>KW-0514</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>350</Position>
      <Original>Ser</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>68</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>118</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>3</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>45</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>43</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>271</Position>
      <Original>Met</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>223</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>282</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>134</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>258</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>274</Position>
      <Original>Ala</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>248</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>258</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>227</Position>
      <Original>Asn</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>75</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>375</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>136</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>148</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>248</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>42</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>198</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>288</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>181</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>17</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>138</Position>
      <Original>Ile</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>150</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>96</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>165</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>336</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>338</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>27</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>184</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>229</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>140</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>185</Position>
      <Original>Arg</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>142</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>181</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>117</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>226</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>359</Position>
      <Original>Ile</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>375</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>374</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>116</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>165</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>226</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>199</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>229</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>185</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>334</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>117</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>294</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>44</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>338</Position>
      <Original>Lys</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>285</Position>
      <Original>Met</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>66</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>85</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>156</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>75</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>181</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>372</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>79</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>77</Position>
      <Original>Ile</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>185</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>185</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>37</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>243</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>229</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>172</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>74</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>253</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>261</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>40</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>265</Position>
      <Original>Gln</Original>
      <Variation>Leu</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The sliding of actin thin filaments and myosin thick filaments past each other in muscle contraction. This involves a process of interaction of myosin located on a thick filament with actin located on a thin filament. During this process ATP is split and forces are generated.</Detail>
      <Keyword>Muscle filament sliding</Keyword>
      <Ontology_ID>GO:0030049</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The aggregation, arrangement and bonding together of proteins to form the actin-based thin filaments of myofibrils in skeletal muscle.</Detail>
      <Keyword>Skeletal muscle thin filament assembly</Keyword>
      <Ontology_ID>GO:0030240</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the skeletal muscle fiber over time, from its formation to the mature structure. Muscle fibers are formed by the maturation of myotubes. They can be classed as slow, intermediate/fast or fast.</Detail>
      <Keyword>Skeletal muscle fiber development</Keyword>
      <Ontology_ID>GO:0048741</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>46</Position>
      <PTM_Type>Methionine sulfoxide</PTM_Type>
    </PTM>
    <PTM>
      <Position>3</Position>
      <PTM_Type>N-acetylaspartate</PTM_Type>
    </PTM>
    <PTM>
      <Position>63</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>193</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>63</Position>
      <PTM_Type>N6-malonyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>93</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>330</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>70</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>55</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>328</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>242</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>75</Position>
      <PTM_Type>Tele-methylhistidine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MCDEDETTALVCDNGSGLVKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQSKRGILTLKYPIEHGIITNWDDMEKIWHHTFYNELRVAPEEHPTLLTEAPLNPKANREKMTQIMFETFNVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYEGYALPHAIMRLDLAGRDLTDYLMKILTERGYSFVTTAEREIVRDIKEKLCYVALDFENEMATAASSSSLEKSYELPDGQVITIGNERFRCPETLFQPSFIGMESAGIHETTYNSIMKCDIDIRKDLYANNVMSGGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWITKQEYDEAGPSIVHRKCF</Protein_Seq>
    <DNA_Seq>ACCGCAGCGGACAGCGCCAAGTGAAGCCTCGCTTCCCTCCCGCGGCGACCAGGGCCCGAGCCGAGAGTAGCAGTTGTAGCTACCCGCCCAGAAACTAGACACAATGTGCGACGAAGACGAGACCACCGCCCTCGTGTGCGACAATGGCTCCGGCCTGGTGAAAGCCGGCTTCGCCGGGGATGACGCCCCTAGGGCCGTGTTCCCGTCCATCGTGGGCCGCCCCCGACACCAGGGCGTCATGGTCGGTATGGGTCAGAAAGATTCCTACGTGGGCGACGAGGCTCAGAGCAAGAGAGGTATCCTGACCCTGAAGTACCCTATCGAGCACGGCATCATCACCAACTGGGATGACATGGAGAAGATCTGGCACCACACCTTCTACAACGAGCTTCGCGTGGCTCCCGAGGAGCACCCCACCCTGCTCACCGAAGCCCCCCTCAATCCCAAGGCCAACCGCGAGAAGATGACCCAGATCATGTTTGAGACCTTCAACGTGCCCGCCATGTACGTGGCCATCCAGGCCGTGCTGTCCCTCTACGCCTCCGGCAGGACCACCGGCATCGTGCTGGACTCCGGCGACGGCGTCACCCACAACGTGCCCATTTATGAGGGCTACGCGCTGCCGCACGCCATCATGCGCCTGGACCTGGCGGGCCGCGATCTTACCGACTACCTGATGAAGATCCTCACTGAGCGTGGCTACTCCTTCGTGACCACAGCTGAGCGCGAGATCGTGCGCGACATCAAGGAGAAGCTGTGCTACGTGGCCCTGGACTTCGAGAACGAGATGGCGACGGCCGCCTCCTCCTCCTCCCTGGAAAAGAGCTACGAGCTGCCAGACGGGCAGGTCATCACCATCGGCAACGAGCGCTTCCGCTGCCCGGAGACGCTCTTCCAGCCCTCCTTCATCGGTATGGAGTCGGCGGGCATTCACGAGACCACCTACAACAGCATCATGAAGTGTGACATCGACATCAGGAAGGACCTGTATGCCAACAACGTCATGTCGGGGGGCACCACGATGTACCCTGGGATCGCTGACCGCATGCAGAAAGAGATCACCGCGCTGGCACCCAGCACCATGAAGATCAAGATCATCGCCCCGCCGGAGCGCAAATACTCGGTGTGGATCGGCGGCTCCATCCTGGCCTCGCTGTCCACCTTCCAGCAGATGTGGATCACCAAGCAGGAGTACGACGAGGCCGGCCCTTCCATCGTCCACCGCAAATGCTTCTAGACACACTCCACCTCCAGCACGCGACTTCTCAGGACGACGAATCTTCTCAATGGGGGGGCGGCTGAGCTCCAGCCACCCCGCAGTCACTTTCTTTGTAACAACTTCCGTTGCTGCCATCGTAAACTGACACAGTGTTT</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoskeleton</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>ACTA1</Gene_Name>
    <Gene_Alias>ACTA</Gene_Alias>
    <Gene_ID>58</Gene_ID>
    <Genbank_ACCN>NM_001100</Genbank_ACCN>
    <Protein_ACCN>NP_001091</Protein_ACCN>
    <HGNC_ID>129</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/58</Gene_URL>
    <UCSC_ID>uc001htm.3</UCSC_ID>
    <EMBL_ID>ENSG00000143632</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Myopathy, Actin, Congenital, with Excess of Thin Myofilaments</Disease_Name>
      <Disease_Detail>Myopathy</Disease_Detail>
      <Disease_DB>MYP028</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myopathy_actin_congenital_with_excess_of_thin_myofilaments?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cap Myopathy</Disease_Name>
      <Disease_Detail>Cap Myopathy</Disease_Detail>
      <Disease_DB>CPM001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cap_myopathy?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intranuclear Rod Myopathy</Disease_Name>
      <Disease_Detail>Intranuclear Rod Myopathy</Disease_Detail>
      <Disease_DB>INT109</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intranuclear_rod_myopathy?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Childhood Restrictive Cardiomyopathy</Disease_Name>
      <Disease_Detail>Childhood Restrictive Cardiomyopathy</Disease_Detail>
      <Disease_DB>CHL087</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/childhood_restrictive_cardiomyopathy?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nance-Horan Syndrome</Disease_Name>
      <Disease_Detail>Nance-Horan Syndrome</Disease_Detail>
      <Disease_DB>NNC002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nance_horan_syndrome?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Typical Nemaline Myopathy</Disease_Name>
      <Disease_Detail>Typical Nemaline Myopathy</Disease_Detail>
      <Disease_DB>TYP021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/typical_nemaline_myopathy?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Actin-Accumulation Myopathy</Disease_Name>
      <Disease_Detail>Actin-Accumulation Myopathy</Disease_Detail>
      <Disease_DB>ACT130</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/actin_accumulation_myopathy?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intermediate Nemaline Myopathy</Disease_Name>
      <Disease_Detail>Intermediate Nemaline Myopathy</Disease_Detail>
      <Disease_DB>INT153</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intermediate_nemaline_myopathy?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myopathy, Actin, Congenital, with Cores</Disease_Name>
      <Disease_Detail>Myopathy</Disease_Detail>
      <Disease_DB>MYP029</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myopathy_actin_congenital_with_cores?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nemaline Myopathy 3, Autosomal Dominant or Recessive</Disease_Name>
      <Disease_Detail>Nemaline Myopathy</Disease_Detail>
      <Disease_DB>NML015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nemaline_myopathy_3_autosomal_dominant_or_recessive?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myopathy, Congenital, with Fiber-Type Disproportion 1</Disease_Name>
      <Disease_Detail>Myopathy</Disease_Detail>
      <Disease_DB>MYP030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myopathy_congenital_with_fiber_type_disproportion_1?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Listeriosis</Disease_Name>
      <Disease_Detail>Listeriosis</Disease_Detail>
      <Disease_DB>LST001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/listeriosis?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Severe Congenital Nemaline Myopathy</Disease_Name>
      <Disease_Detail>Severe Congenital Nemaline Myopathy</Disease_Detail>
      <Disease_DB>SVR040</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/severe_congenital_nemaline_myopathy?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acta1-Related Nemaline Myopathy</Disease_Name>
      <Disease_Detail>Acta1-Related Nemaline Myopathy</Disease_Detail>
      <Disease_DB>ACT122</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acta1_related_nemaline_myopathy?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acta1-Related Congenital Fiber-Type Disproportion</Disease_Name>
      <Disease_Detail>Acta1-Related Congenital Fiber-Type Disproportion</Disease_Detail>
      <Disease_DB>ACT121</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acta1_related_congenital_fiber_type_disproportion?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nemaline Myopathy 5, Amish Type</Disease_Name>
      <Disease_Detail>Nemaline Myopathy</Disease_Detail>
      <Disease_DB>NML020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nemaline_myopathy_5_amish_type?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nemaline Myopathy</Disease_Name>
      <Disease_Detail>Nemaline Myopathy</Disease_Detail>
      <Disease_DB>NML001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nemaline_myopathy?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nemaline Myopathy 3</Disease_Name>
      <Disease_Detail>Nemaline Myopathy</Disease_Detail>
      <Disease_DB>NML004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nemaline_myopathy_3?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myopathy</Disease_Name>
      <Disease_Detail>Myopathy</Disease_Detail>
      <Disease_DB>MYP004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myopathy?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Congenital Fiber-Type Disproportion</Disease_Name>
      <Disease_Detail>Congenital Fiber-Type Disproportion</Disease_Detail>
      <Disease_DB>CNG046</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/congenital_fiber_type_disproportion?search=ACTA1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Childhood-Onset Nemaline Myopathy</Disease_Name>
      <Disease_Detail>Childhood-Onset Nemaline Myopathy</Disease_Detail>
      <Disease_DB>CHL107</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/childhood_onset_nemaline_myopathy?search=ACTA1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Structural basis of actin sequestration by thymosin-B4: Implications for arp2/3 activation</PDB_Title>
      <PDB_ID>1T44</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1T44</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of actin sequestration by thymosin-beta4: implications for WH2 proteins.</PubMed_Title>
      <Author>Irobi, E., et al.</Author>
      <Journal>Embo J.(2004)23:3599-3608</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15329672?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04510</Pathway_ID>
      <Pathway_Title>Focal adhesion</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04391</Pathway_ID>
      <Pathway_Title>Hippo signaling pathway - fly</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05131</Pathway_ID>
      <Pathway_Title>Shigellosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05132</Pathway_ID>
      <Pathway_Title>Salmonella infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05132</Pathway_ID>
      <Pathway_Title>Salmonella infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04520</Pathway_ID>
      <Pathway_Title>Adherens junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04530</Pathway_ID>
      <Pathway_Title>Tight junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04745</Pathway_ID>
      <Pathway_Title>Phototransduction - fly</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Sensory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05110</Pathway_ID>
      <Pathway_Title>Vibrio cholerae infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05100</Pathway_ID>
      <Pathway_Title>Bacterial invasion of epithelial cells</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04670</Pathway_ID>
      <Pathway_Title>Leukocyte transendothelial migration</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04810</Pathway_ID>
      <Pathway_Title>Regulation of actin cytoskeleton</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell motility</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04810</Pathway_ID>
      <Pathway_Title>Regulation of actin cytoskeleton</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell motility</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05416</Pathway_ID>
      <Pathway_Title>Viral myocarditis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cardiovascular diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04745</Pathway_ID>
      <Pathway_Title>Phototransduction - fly</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Sensory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04670</Pathway_ID>
      <Pathway_Title>Leukocyte transendothelial migration</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04810</Pathway_ID>
      <Pathway_Title>Regulation of actin cytoskeleton</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell motility</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04611</Pathway_ID>
      <Pathway_Title>Platelet activation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04670</Pathway_ID>
      <Pathway_Title>Leukocyte transendothelial migration</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04520</Pathway_ID>
      <Pathway_Title>Adherens junction</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cellular commiunity</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05130</Pathway_ID>
      <Pathway_Title>Pathogenic Escherichia coli infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04390</Pathway_ID>
      <Pathway_Title>Hippo signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04919</Pathway_ID>
      <Pathway_Title>Thyroid hormone signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04921</Pathway_ID>
      <Pathway_Title>Oxytocin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04015</Pathway_ID>
      <Pathway_Title>Rap1 signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05100</Pathway_ID>
      <Pathway_Title>Bacterial invasion of epithelial cells</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD03230002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03230003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03230004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03230005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03230006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03230007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03230009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03230010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05250006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10030002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>